Provided by Tiger Trade Technology Pte. Ltd.

Companhia Siderurgica Nacional

0.9772
+0.08599.64%
Post-market: 0.9600-0.0172-1.76%19:30 EDT
Volume:2.05M
Turnover:1.95M
Market Cap:1.30B
PE:-2.56
High:0.9800
Open:0.8800
Low:0.8800
Close:0.8913
52wk High:2.20
52wk Low:0.8365
Shares:1.33B
Float Shares:625.00M
Volume Ratio:1.39
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3824
EPS(LYR):-0.2741
ROE:-12.29%
ROA:2.17%
PB:0.52
PE(LYR):-3.56

Loading ...

Companhia Siderurgica Nacional SA Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Announcement of Final Results of Private Exchange Offer for CSN Inova Ventures’ Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation

GlobeNewswire
·
Aug 11

Companhia Siderurgica Nacional SA Expected to Post Earnings of 10 Centavos a Share - Earnings Preview

Reuters
·
Aug 11

Indonesia Logs 30.27 Million Capital Market Investors

Tempo
·
Aug 11

Earning Preview: Companhia Siderurgica Nacional Q2 revenue is expected to increase by 0.52%, and institutional views are unavailable

Earnings Agent
·
Aug 05

Singapore small and mid-caps narrow corporate governance performance gap with larger peers

Felicia Tan
·
Aug 05

Press Release: Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures' Outstanding 6.750% Senior Notes Due 2028 and Consent Solicitation

Dow Jones
·
Jul 31

SID's new guide helps boards assess the value and risks of AI

Nurdianah Md Nur
·
Jul 31

Danantara Begins Merger of Four State-Owned Investment Firms

Tempo
·
Jul 23

Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins

GlobeNewswire
·
Jul 16

Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology

GlobeNewswire
·
May 15

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

GlobeNewswire
·
May 15

Revised Title

Stock News
·
May 14

Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 13

Companhia Siderurgica Nacional SA expected to post earnings of 84 centavos a share - Earnings Preview

Reuters
·
May 12

Press Release: Evommune Reports First Quarter 2026 Financial Results and Provides Business Highlights

Dow Jones
·
May 08

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

GlobeNewswire
·
May 08

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 08

Earning Preview: Companhia Siderurgica Nacional this quarter’s revenue is expected to decrease by 3.85%, and institutional views are neutral

Earnings Agent
·
May 06

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting

GlobeNewswire
·
May 06